Oncology · Precision Cancer Testing

Targeted Cancer Panels
Disease-specific NGS Panels

Focused oncology panels delivering rapid and cost-effective molecular profiling.

FFPE/Blood
Sample Type
1 FFPE block or 10–15 slides
Samples
10–14 working days
Turnaround Time

Targeted Cancer Panels at Nucleome Informatics

Disease-specific NGS Panels

Why this Test Matters

Precision oncology depends on identifying clinically actionable genomic alterations. This assay helps clinicians select targeted therapies, evaluate immunotherapy eligibility, identify prognostic biomarkers, detect resistance mechanisms, and match patients to suitable clinical trials while minimizing sequential testing.

Who Should Consider this Test

  • Defined clinical indication
  • Cost-sensitive testing

Applicable Cancer Types

Solid tumors, Hereditary cancers, Lung cancer

What the test covers and delivers

What is Covered

  • Pan Cancer 86 genes
  • Hotspot panel
  • Hereditary Oncology 47 genes
  • Lung Fusion panel

Clinical Utility​

  • Treatment selection
  • Prognostic and predictive biomarkers
  • Clinical trial matching
  • Identification of actionable alterations
  • Comprehensive clinical interpretation

Technology

Targeted high-depth NGS

Test specifications

ParameterDetails
Sample TypeFFPE/Blood
Samples1 FFPE block or 10–15 slides
Turnaround Time10–14 working days
Report IncludesVariant interpretation, therapy associations, clinically actionable biomarkers
QualityHigh-depth NGS with rigorous QC
Talk to our team. Email info@nucleomeinfo.com or call +91 40 40114169 to discuss sample requirements and turnaround for Targeted Cancer Panels.